Current studies have shown that ERK1/2, P38 MAPK, and JNK are able to be activated in COPD, release inflammatory factors, promote mucin expression, and regulate cytokine transcription [1]. This evidence concerns the gene MAPK3 and chronic obstructive pulmonary disease.